Results

Total Results: 1,868 records

Showing results for "drug".

  1. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Magid.pdf
    January 01, 2004 - Relationship between medication errors and adverse drug events. … Computer adverse drug event (ADE) detection and alerts. … Drug-related morbidity and mortality. A cost-of-illness model. … Top-priority actions for preventing adverse drug events in hospitals. … The clinical pharmacist’s role in preventing adverse drug events.
  2. www.ahrq.gov/es/patient-safety/settings/hospital/red/toolkit/postdischarge-doc.html
    March 01, 2025 - Medicine list for appropriate dosing, drug-drug and drug-food interactions, and major side effects. … ___ No change needed in discharge plan as it relates to the drug therapy ___ Educated patient/caregiver … ___ No change needed in discharge plan as it relates to the drug therapy ___ Educated patient/caregiver … ___ No change needed in discharge plan as it relates to the drug therapy ___ Educated patient/caregiver
  3. Postdiscalldoc (doc file)

    www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/settings/hospitals/red-toolkit/postdiscalldoc.docx
    June 02, 2025 - phone call: Review: Health history Medicine lists for consistency Medicine list for appropriate dosing, drug-drug … and drug-food interactions, and major side effects Contact sheet DE notes Discharge summary and AHCP … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper
  4. www.ahrq.gov/patient-safety/settings/hospital/red/toolkit/postdischarge-doc.html
    March 01, 2025 - Medicine list for appropriate dosing, drug-drug and drug-food interactions, and major side effects. … ___ No change needed in discharge plan as it relates to the drug therapy ___ Educated patient/caregiver … ___ No change needed in discharge plan as it relates to the drug therapy ___ Educated patient/caregiver … ___ No change needed in discharge plan as it relates to the drug therapy ___ Educated patient/caregiver
  5. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
    April 30, 2025 - drug events in older adults. … This article addresses five areas: (1) pediatric drug development and drug trials; (2) comparative … Patient-centered-medical-home was not protective for drug-drug interactions or LOLU. … Another option was to import the drug into the software without reentering detailed, complicated drug … interactions, and drug-disease interactions and monitoring or preventing adverse drug events.
  6. www.ahrq.gov/sites/default/files/2024-02/gurwitz2-report.pdf
    January 01, 2024 - drug classes as key targets for reducing the risk of drug-related injuries: anticoagulants, diabetes … Event Prevention: Targeting High-Risk Drug Classes: The National Action Plan for Adverse Drug Event … Prevention identified three high-priority drug classes as key targets for reducing the risk of drug-related … incidents, of which 80% (154) were characterized as adverse drug events or potential adverse drug events … The combined incidence rate of adverse drug events and potential adverse drug events in the intervention
  7. www.ahrq.gov/sites/default/files/wysiwyg/nhguide/4_TK2_T4-Common_Suspected_Infections_Tools_to_Improve_Communication_and_Decision_Making.ppt
    May 01, 2014 - * Quality Improvement for Antibiotic Prescribing Problems with taking antibiotics Drug resistance … vomiting, diarrhea Secondary infections: C difficile, yeast Allergic reactions: rash, anaphylaxis Drug … In developing countries, multi-drug resistant tuberculosis in an ever-increasing challenge. … The price of innovation: new estimates of drug development costs.  … Yet if antibiotic resistance does develop, it will limit the effective lifespan of the drug.
  8. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/medmanagement_webinar_slides.pdf
    January 01, 2015 - Therapeutic Drug Use. [updated 2016 July 6; cited 2016 Aug 1]. … Available from: http://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm 2. … Adverse drug events in U.S. adult ambulatory medical care. … http://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm http://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm … http://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm http://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm
  9. www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chap5tab20.html
    December 01, 2017 - Therapeutic nutrients/ minerals/ electrolytes 128,643 2.4% Vitamins 195,791 3.6% Other drug … classes a 575,199 10.5% No drug class assignment 517,926 9.5%       All … 100.0% a  10.4% of medications were accounted for by 19 Veteran's Administration Therapeutic drug
  10. www.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
    January 01, 2024 - Food and Drug Administration Adverse Event Reporting System (FAERS). … Expert Opin Drug Saf. 2017;16(7):761-767. 3. Bourgeois FT, Shannon MW, Valim C, Mandl KD. … Adverse drug events in the outpatient setting: an 11-year national analysis. … Pharmacoepidemiology and drug safety. 2010;19(9):901-910. 4. Perrillo RP, Martin P, Lok AS. … Food and Drug Administration and Federal Trade Commission.
  11. www.ahrq.gov/sites/default/files/2024-07/weingart2-report.pdf
    January 01, 2024 - drug allergies (IRR 4.8, 95% CI 1.7-13.5). … Patients experienced 21 total adverse drug events; they reported 17 electronically. … Physicians’ decisions to override computerized drug alerts in primary care. … Lessons from a patient partnership intervention to prevent adverse drug events. … Computerized surveillance of adverse drug events in hospitalized patients.
  12. Postdiscalldoc (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/settings/hospitals/red-toolkit/postdiscalldoc.pdf
    June 02, 2025 - : Review: Health history Medicine lists for consistency Medicine list for appropriate dosing, drug-drug … and drug-food interactions, and major side effects Contact sheet DE notes Discharge summary and …  No change needed in discharge plan as it relates to the drug therapy  Educated patient/caregiver …  No change needed in discharge plan as it relates to the drug therapy  Educated patient/caregiver …  No change needed in discharge plan as it relates to the drug therapy  Educated patient/caregiver
  13. www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide219.html
    October 01, 2014 - National Institute on Drug Abuse: www.nida.nih.gov Office on Smoking and Health at the Centers for
  14. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/0085-tech-specs.pdf
    January 01, 2012 - following screenings at the first prenatal visit: screening for depression, alcohol use, tobacco use, drug … visit Tobacco use screening Patients who were screened for tobacco use* at the first visit Drug … use (illicit and prescription, over the counter) screening Patients who were screened for any drug … use, prescription drug use and over the counter drug use. … Illicit, Prescription and Over the Counter Drug Use ScreeningRisk Category/Assessment For the purposes
  15. Clinical Topic (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085textdesc.pdf
    January 01, 2012 - following screenings at the first prenatal visit: screening for depression, alcohol use, tobacco use, drug … visit Tobacco use screening Patients who were screened for tobacco use* at the first visit Drug … use (illicit and prescription, over the counter) screening Patients who were screened for any drug … use, prescription drug use and over the counter drug use. … Illicit, Prescription and Over the Counter Drug Use ScreeningRisk Category/Assessment For the purposes
  16. www.ahrq.gov/sites/default/files/2024-01/weingart-report.pdf
    January 01, 2024 - Key vulnerabilities include patient education about drug handling and adverse effects; safe prescription … Key Words: failure modes and effects analysis, oral medication, antineoplastic drug, medication error … searching summaries and analyses of sentinel events reported by organizations such as the Food and Drug … We planned to categorize reports by drug, disease, type and severity of injury, and error type. … The scope of each FMEA varied slightly due to the customary use of each drug in clinical practice.
  17. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/OConnor.pdf
    November 29, 2004 - Inappropriate or risky drug prescribing occurred in 9.9 percent of the 5,729 patients. … Among the categories of drug-related medical errors are those related to drug-drug interactions, use … dl With drug intensification 159 3.8% LDL ≥ 130 mg/dl No drug intensification 536 12.9% Triglycerides … +Drug-fill date more than 4 weeks after test date. … +Type 1 lipid error is inadequate drug treatment when LDL ranges 100-129 mg/dl.
  18. www.ahrq.gov/sites/default/files/2024-01/wessell-report.pdf
    January 01, 2024 - practice performance in five categories of MS: avoiding potentially inappropriate therapy, dosages, drug-drug … interactions, drug-disease interactions, and monitoring of potential adverse events. … Two drug-drug interaction indicators (ACE inhibitors or ARBs with potassium-sparing diuretics in elderly … elderly • Digoxin in the elderly with CHF • H2 blockers based on renal function Avoiding Potential Drug-Drug … and monitoring of potential adverse drug events.
  19. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.
  20. References (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: